G20 India Summit: Enhance the global healthcare ecosystem
A review article by
Dr Bhavana Kalvala (Clinical Research Director @ IEEARC Tech)
As the G20 India summit unfolds The theme for the G20 Summit 2023 is “Vasudhaiva Kutumbakam One Earth One Family One Future, We take pride in our commitment to leveraging our expertise and knowledge to enhance the global healthcare ecosystem.
For its G-20 presidency, India has identified three areas of health as priorities. Preventing, preparing for, and responding to health emergencies with a focus on the One Health paradigm and antimicrobial resistance (AMR).
Second, improving collaboration in the pharmaceutical industry with an emphasis on access and availability of vaccines, medicines, and diagnostics that are safe, effective, high-quality, and inexpensive.
Third, improvements in healthcare service delivery and advances in digital health to support universal health coverage. Digital health is not just maintaining a long-term, accessible record of the trajectory, medical reports, and treatment regimes of individual patients, transferable across states and possibly across countries, and will be an increasingly important dimension of health in the future.
Our startup IEEARC Tech harness health data to improve patient care by predicting diseases like heart attack.
INIGIMA Cloud Diagnosis is a Data-driven digital health intervention that plays a pivotal role in improving health. It empowers individuals in managing their health and wellness, assists care providers in adhering to guidelines and delivering high-quality care, facilitates precision medication for patients and promotes longevity.
Why it’s important now?
The Covid-19 pandemic showed significant shortcomings in nations’ ability to provide healthcare in a pandemic emergency. Throughout a large portion of the COVID-19 pandemic, efforts to reduce the disparities in vaccination access between high- and low-income nations were unsuccessful. Future policies must take into account the lessons learned from this mistake.
+ There are no comments
Add yours